Orly Alter

Biography
Orly Alter is a USTAR associate professor at the Scientific Computing and Imaging Institute and the Huntsman Cancer Institute at the University of Utah, a scientific advisory board member of the NCI-DOE Cancer Moonshot collaboration on predictive oncology, and the CSO and a co-founder of Prism AI. Her Ph.D. thesis in applied physics at Stanford University is recognized as crucial to quantum computing. Inventor of the “eigengene," Alter develops AI/ML to compare and integrate datasets of any types, number and dimensions, and sizes. She demonstrated that her algorithms, the multi-tensor comparative spectral decompositions, discover interpretable and actionable predictors, applicable to the general population from as few as 50–100 patients, and her predictors outperform all others, where they exist. Her retrospective clinical trial experimentally validated a genome-wide pattern in brain cancer tumors as the most accurate and precise predictor of life expectancy and response to standard of care.

---

Talk
AI-Powered Biomarker Discovery for Personalized Medicine
The ability to detect complex multi-omic differential signatures is the basis for personalized medicine. But with typical AI this process rarely converges into an effective solution. We will present a powerful and novel AI approach for the discovery of biomarkers and drug targets from real-life, small-cohort, multi-omic, and noisy data.

Clinical & Research Tools Showcase:
Prism AI
Prism AI offers an AI-first clinical multi-omic data management and analytics platform that allows biotech companies and health systems to unlock the potential of their own data and create the next generation of drugs and biomarkers.